Quarterly report · Q1

Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥182.1bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥690.5bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥166.5bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥9.9bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥9.1bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥10.1bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥38.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥9.2bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥10.1bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥9.2bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥6.9bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥25.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥6.3bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥6.9bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥6.3bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥353.5bnat 2023-06-30Cons.Assets
Total assets¥360.7bnat 2023-03-31Cons.Assets
Total assets¥326.3bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥116.1bnat 2023-06-30Cons.Liabilities
Total liabilities¥124.3bnat 2023-03-31Cons.Liabilities
Net assets / equity¥237.4bnat 2023-06-30Cons.Net assets
Net assets / equity¥236.3bnat 2023-03-31Cons.Net assets
Net assets / equity¥222.7bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥68.8bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥80.9bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥59.022023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥219.832022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥53.872022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥59.012023-04-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥219.822022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥53.862022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio67.1%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio65.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio68.2%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥13.1bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥13.1bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue2023-04-01 → 2023-06-30¥75.9bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue external2023-04-01 → 2023-06-30¥75.9bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥2m
jpcrp040300-q1r_E03226-000Discount Storereportable segmentsegment profit2023-04-01 → 2023-06-30¥3.9bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue2023-04-01 → 2023-06-30¥119.3bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue external2023-04-01 → 2023-06-30¥106.2bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥13.1bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentsegment profit2023-04-01 → 2023-06-30¥6.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥195.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥182.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥13.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥9.9bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥12.4bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥12.4bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue2022-04-01 → 2022-06-30¥70.4bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue external2022-04-01 → 2022-06-30¥70.4bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥3m
jpcrp040300-q1r_E03226-000Discount Storereportable segmentsegment profit2022-04-01 → 2022-06-30¥3.4bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue2022-04-01 → 2022-06-30¥108.5bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue external2022-04-01 → 2022-06-30¥96.1bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentsegment profit2022-04-01 → 2022-06-30¥5.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥178.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥166.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥12.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥9.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 333
ItemContextValueUnit
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-08-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第61期第1四半期(自 2023年4月1日 至 2023年6月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社サンドラッグ
Company name in english cover pageFilingDateInstantSUNDRUG CO.,LTD.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長 CEO  貞方 宏司
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都府中市若松町一丁目38番地の1
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)042(369)6211(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)執行役員 管理本部長 加藤 好伸
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都府中市若松町一丁目38番地の1
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)042(369)6211(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)執行役員 管理本部長 加藤 好伸
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE03226
Fund codeFilingDateInstant-
Security codeFilingDateInstant99890
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社サンドラッグ
Filer name in englishFilingDateInstantSUNDRUG CO.,LTD.
Fund name in japaneseFilingDateInstant-
Fund name in englishFilingDateInstant-
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstant-
Current fiscal year start dateFilingDateInstant2023-04-01
Current period end dateFilingDateInstant2023-06-30
Type of current periodFilingDateInstantQ1
Current fiscal year end dateFilingDateInstant2024-03-31
Previous fiscal year start dateFilingDateInstant2022-04-01
Comparative period end dateFilingDateInstant2022-06-30
Previous fiscal year end dateFilingDateInstant2023-03-31
Next fiscal year start dateFilingDateInstant-
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant-
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant-
Report amendment flagFilingDateInstantfalse
Xbrl amendment flagFilingDateInstantfalse
Business results of group (text)FilingDateInstantText · Plus
Description of business (text)FilingDateInstantText · Plus
Business risks (text)FilingDateInstantText · Plus
Management analysis of financial position operating results and cash flows (text)FilingDateInstantText · Plus
Critical contracts for operation (text)FilingDateInstantText · Plus
Total number of shares (text)FilingDateInstantText · Plus
Issued shares total number of shares etc (text)FilingDateInstantText · Plus
Class issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)普通株式
Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registeredFilingDateInstant_OrdinaryShareMember
Original text (Japanese)東京証券取引所プライム市場
Description issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)単元株式数100株
Details of employee share option program (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass